Does the oral contraceptive Finestride (cyproterone acetate 2 mg/ethinyl‑estradiol 0.035 mg) reduce skin oiliness and improve skin clarity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Finasteride Does Not Reduce Skin Oiliness or Improve Skin Clarity

Finasteride is NOT the medication you're asking about - you appear to be confusing finasteride (a 5α-reductase inhibitor used for male pattern baldness and prostate enlargement) with a combined oral contraceptive containing cyproterone acetate/ethinyl estradiol. Finasteride is actually contraindicated in women of reproductive potential due to risk of genital abnormalities in male fetuses 1.

What You're Actually Asking About

Based on your expanded question mentioning "cyproterone acetate 2 mg/ethinyl-estradiol 0.035 mg," you're asking about a combined oral contraceptive (COC), not finasteride.

Does Cyproterone Acetate/Ethinyl Estradiol Reduce Oiliness and Clear Skin?

Yes, cyproterone acetate 2 mg combined with ethinyl estradiol 35 μg (CPA/EE) effectively reduces skin oiliness (seborrhea) and clears acne through its antiandrogenic properties [@2-5@, 2].

Mechanism of Action

CPA/EE works through multiple antiandrogenic pathways 2, 3:

  • Inhibits androgen receptors directly (cyproterone acetate's primary action)
  • Suppresses ovarian androgen production via gonadotropin suppression
  • Increases sex hormone-binding globulin (SHBG), binding free testosterone and making it unavailable
  • Reduces 5α-reductase activity, decreasing conversion of testosterone to DHT
  • Directly reduces sebaceous gland activity, leading to less oily skin

Clinical Evidence for Skin Improvement

Acne Reduction

A large multicenter study of 890 women with facial acne showed 4:

  • 82.8% achieved "good" or "very good" response (>50% lesion reduction) after 6 cycles
  • Reductions in all lesion types: comedones (75.6-80%), papules (88.4%), pustules (85.1%)
  • 64.3% showed lower acne grade by study end
  • Only 4.9% experienced worsening

Seborrhea (Oiliness) Reduction

Multiple studies confirm CPA/EE significantly reduces sebum production 5, 6:

  • Direct measurement showed marked reduction in sebum output
  • Clinical improvement in seborrhea observed alongside acne improvement
  • Effects maintained throughout treatment duration

Comparative Effectiveness

When compared to other COCs 5, 7:

  • CPA/EE performs as well or better than other antiandrogenic COCs for acne and seborrhea
  • Superior to levonorgestrel-containing COCs 7
  • Comparable efficacy to drospirenone-containing COCs 3

Important Clinical Considerations

Time to Effect

  • Minimum 6-month trial recommended before assessing full response 8, 3
  • Improvements typically begin within 3 months but continue to increase
  • Sebum reduction may be noticed earlier than complete acne clearance

Safety Profile

CPA/EE carries standard COC risks [@3-5@]:

Venous Thromboembolism (VTE):

  • Baseline risk: 1-5 per 10,000 woman-years (non-users)
  • CPA/EE users: 3-9 per 10,000 woman-years
  • 50-80% higher VTE risk than levonorgestrel-COCs but still low absolute risk 2

Contraindications include:

  • Age ≥35 years with smoking
  • History of VTE, stroke, or MI
  • Uncontrolled hypertension
  • Migraine with aura (if ≥35 years)
  • Current or recent breast cancer
  • Pregnancy or breastfeeding <6 weeks postpartum 2

Who Benefits Most

Best candidates for CPA/EE 8, 6, 9:

  • Women with moderate-to-severe acne related to androgen sensitivity
  • Those with accompanying seborrhea (oily skin)
  • Women with polycystic ovary syndrome (PCOS)
  • Those experiencing acne flares around menses
  • Women who also desire contraception (FDA requirement for acne indication)

Common Pitfall to Avoid

Do not confuse finasteride with CPA/EE. Finasteride is:

  • A 5α-reductase inhibitor used in men for hair loss and prostate issues 1
  • Absolutely contraindicated in women who may become pregnant 1
  • Has limited evidence in women (only studied for hirsutism at 5-7.5 mg doses) 3, 10
  • Does NOT have the same comprehensive antiandrogenic effects as CPA/EE

The correct medication for reducing skin oiliness and clearing acne in women is cyproterone acetate 2 mg/ethinyl estradiol 35 μg, not finasteride.

References

Guideline

guidelines of care for the management of acne vulgaris.

Journal of the American Academy of Dermatology, 2016

Research

The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2017

Research

Combined oral contraceptive pills for treatment of acne.

The Cochrane database of systematic reviews, 2012

Research

Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2017

Guideline

american association of clinical endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2001

Related Questions

I have been using the combined oral contraceptive diclin (ethinyl estradiol ≈ 30‑35 µg + cyproterone acetate ≈ 2 mg) for over 10 years and want to switch to a regimen that eliminates menstrual bleeding; what options are available and what considerations should I discuss with my clinician?
Why does ethinylestradiol (EE)/cyproterone acetate (CPA) not regulate menstrual cycles?
What are the precautions and alternative treatments for patients taking Diane-35 (cyproterone acetate and ethinyl estradiol)?
Can combined oral contraceptives containing estrogen improve acne in women of reproductive age?
What is the proper usage and dosage of Cyproterone (anti-androgen) for treating conditions like acne or hirsutism?
How should a male patient with a rash persisting for four months be evaluated and managed?
For a sterile pre‑patellar bursa that refills within days after aspiration, should repeated aspiration be performed or should a corticosteroid injection be used?
How should I prescribe ferrous sulfate 325 mg in a liquid formulation for an adult with iron‑deficiency anemia?
What is the recommended dosing schedule for lurasidone (Latuda) in adults with schizophrenia and bipolar I depression, including dose adjustments for hepatic impairment and CYP3A4 inhibitors or inducers?
Can intramuscular Kenalog (triamcinolone acetonide) be used to treat acne?
What is the maximum total daily dose of cloxacillin (oral and intravenous) for adults and for children aged one year and older?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.